Oxyntomodulin reduces hydromineral transport through rat small intestine
- PMID: 9724174
- DOI: 10.1023/a:1018804307972
Oxyntomodulin reduces hydromineral transport through rat small intestine
Abstract
Glicentin (GLIC) and oxyntomodulin (OXM) are released from the ileum and colon during digestion. Both hormones reduce fluid and proton secretion in the stomach. The luminal concentration of sodium and chloride underlying the nutrient absorption, the effect of OXM on electrolyte transport through the small intestine, was assessed in vivo using ligated loops and in vitro using Ussing chambers. In vivo, a zero transport state, estimated by the net water, chloride, and sodium fluxes, was observed when an 80 mM NaCl normoosmolar solution (274 mosm) was administered intraluminally. Active secretion was observed with hyperosmotic challenge (474 mosm). The amplitude of this active secretion increased 2.5- to 3-fold when an electrogenic challenge (NaCl 40 mM) was substituted to the hyperosmotic one. OXM (800 fmol/ml plasma) did not modify the basal transport in the duodenum or in the jejunum (t = 45 min). When active secretion was induced by the hyperosmotic challenge, OXM (200 fmol/ml plasma) had no effect on duodenal or jejunal transport (t = 50 min). When active secretion was induced by an electrogenic challenge, OXM (300 fmol/ml plasma) preferentially reduced the hydromineral transport in jejunum. In vitro, OXM also induced a reduction in the ion transport towards the jejunal lumen (EC50 = 20 pM), the amplitude of which depended upon the integrity of the tetrodotoxin-sensitive neurons. In conclusion, OXM was able to reduce the large secretion induced in rat jejunum in vivo by an electrogenic gradient. In vitro, the antisecretory effect of OXM was partly mediated by the neurons present in the intrajejunal wall.
Similar articles
-
Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine.Neurogastroenterol Motil. 2004 Aug;16(4):455-63. doi: 10.1111/j.1365-2982.2004.00528.x. Neurogastroenterol Motil. 2004. PMID: 15306001
-
Effect of glicentin, oxyntomodulin and related peptides on isolated gastric smooth muscle cells.Pflugers Arch. 1997 Nov;434(6):729-34. doi: 10.1007/s004240050458. Pflugers Arch. 1997. PMID: 9306005
-
Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats.Pancreas. 2000 May;20(4):348-60. doi: 10.1097/00006676-200005000-00003. Pancreas. 2000. PMID: 10824688
-
The forgotten members of the glucagon family.Diabetes Res Clin Pract. 2014 Oct;106(1):1-10. doi: 10.1016/j.diabres.2014.06.010. Epub 2014 Jul 3. Diabetes Res Clin Pract. 2014. PMID: 25115338 Review.
-
The biological significance of "enteroglucagon." Present status.Peptides. 1986;7 Suppl 1:37-42. doi: 10.1016/0196-9781(86)90161-0. Peptides. 1986. PMID: 3529053 Review.
Cited by
-
Small bowel review: normal physiology part 1.Dig Dis Sci. 2001 Dec;46(12):2567-87. doi: 10.1023/a:1012794505897. Dig Dis Sci. 2001. PMID: 11768247 Review.
-
Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology.J Mol Med (Berl). 2007 Jul;85(7):673-84. doi: 10.1007/s00109-007-0167-4. Epub 2007 Mar 14. J Mol Med (Berl). 2007. PMID: 17356847 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources